Service Hotline +86 400-068-7188
Service Hotline +86 400-068-7188
China Medicine Industry Indepth Research and Investment Strategy Report, 2013-2017
A must-have for enterprise medium to long-term strategic planning
Without deep industry knowledge, it will be difficult to gain any return
English Version：USD7900
Including: Paper back + Electronic Copy + Invoice
Customer Hotline：+86 755 - 82925195 / 82925295
Free Hotline：+86 400-068-7188After-sales Hotline： +86 755-33013088
The Ministry of Commerce of the People's Republic of China designated Qianzhan Industrial Research Institute as the only "regional workstation for dealing with trade friction" in the Guangdong-Hong Kong-Macao Greater Bay Area
Customer Hotline：+86 755 - 82925195 / 82925295
Free Hotline：+86 400-068-7188
0755 - 82925195
400-068-7188
We are aware of that the content of our products have been stolen by some ones who changed the design and used it to deceive customers as it is their own products. Customers who are misled may experience no product received or an incomplete product.
Therefore, Qianzhan Industrial Research Institute encourage you to arrange an in-person visit to our company before you make the purchase.
Qianzhan has the sole copyright of all research reports. We have never had partnership or affiliated with any third party agent. Please recognize the"
"trademark when purchasing reports.To have better investment return or strategic outcomes, you must have a forward-looking vision. Qianzhan Industrial Research Institute - China's leading industry consulting institutions provide you with all the things you need in business!
* The table of contents and the rest of this report are originally created by Qianzhan. Without any prior written permission, it is prohibited to copy or reproduce in any way. To have better investment return or strategic outcomes, you must have a forward-looking vision!
Table of Contents
Content Summary
Major characteristics of this report are forward-looking and timeliness. Base on the forward-looking analysis of massive research data, we further analyze the development scale and competitive landscape of medicine industry. Along with the industry development route and our practical experience, we analyze and predict the future development prospect of medicine industry. This report is of a high value for medicine corporations, R&D institutes, selling corporaitons and investment corporations to accurately know the latest industry development trend, and obtain market opportunities and determine an insightful operation strategy and development direction.
2010 is the second year for the implementation of new medical reform. The constant promotion of new medical reform brings an overall expansion to the medicine market. Currently the domestic per-capita medical consumption is still in the initial stage. The domestic per-capita medical expenditure in 2009 is only 146.6 USD which is far lower than the 7,492.5 USD in America and 822.5 USD of the average level in the world. Its roof is the shortage of government investment which leads to a heavy pressure for individuals and limits the medical treatment demand in long term.
Since the launch of new medical reform in 2009, government began to enhance the investment to medical treatment. The government health expenditure in 2009 reaches 468.6 billion Yuan, up 30.38% compare with that in 2008 while the proportion to fiscal expenditure increases to 6.18%. The proportion of personal medical expenditure is decreasing that it declines to 38.20% in 2009 while the personal pressure is reducing. In order to settle the problem of “difficulty and high cost of medical treatment”, the government expenditure will keep a constantly growth in coming years. Along with the enhancing investment and complete medical treatment system, the released medical treatment demand will promote a fast development of the medicine industry. From a long-term view, the industry demand will grow along with the aging and urbanization that the industry prospects are optimistic.
Major characteristics of this report are forward-looking and timeliness. Base on the forward-looking analysis of massive research data, we further analyze the development scale and competitive landscape of medicine industry. Along with the industry development route and our practical experience, we analyze and predict the future development prospect of medicine industry. This report is of a high value for medicine corporations, R&D institutes, selling corporaitons and investment corporations to accurately know the latest industry development trend, and obtain market opportunities and determine an insightful operation strategy and development direction.
Here, we’d like to express our sincere gratitude to National Statistics Bureau of China, International Information Institute, National Institute of the Ministry of Commerce, National Tsing Hua University Library, Institute of Market Economy of the State Council Development Research Center, and Beijing Qinghua Forward Market Research Center, etc. Thank you so much!
Notice: all the market data, especially the corporation list data in this report is only for business reference. Please don’t take the data for enterprise publicity. Thank you! Or Forward shall not take any responsibility for any consequences!
Qianzhan Business Information Co., Ltd. Industry Research Center
Research Team of Medicine Industry
The National Bureau of Statistics Foreign-related investigation Permission
National Innovation Company and Dual Software Certified Enterprise
The only DRC desginated Enterprise of the Industry Yearbook
National Ministry of Commerce designated Industrial Early Warning and Monitoring Workstation
Guangdong Province Enterprise of Observing Contract and Valuing Credit
Qianzhan is an industry consulting service provider with national innovation company qualification, independent research and development of industrial big data and Dual Software Certification.
Qianzhan is a consulting and research organization that has been engaged in business consulting for over 16 years in China.
Qianzhan is a consulting service provider with a team of nearly 300 industrial researchers and analysts.
Qianzhan is a consulting service provider with an in-house expert pool of 1200 experts.
Qianzhan is a research and consulting organization that have served 180000 clients and received over positive comments from 100000 of our clients.
Qianzhan is an industry research and consulting organization that has been designated by the highest authority, the DRC, to prepare the yearbook.
Qianzhan is an industry planning and consulting organization that adopts the internationally synchronized SCP scientific analysis model and the perfect industry chain research map to guide the business planning and consulting.
Qizhan is a consulting service organization that helps enterprises to solve the five aspects of industry research, planning, strategic design, capital operation and implementation.
Free Hotline：+86 400-068-7188
Customer Hotline：+86 755 - 82925195 / 82925295
Email Address：service@qianzhan.com
3rd Floor, FIYTA Building West, High Tech South Avenue 1, Nanshan District, Shenzhen, China
Location：Rm.1106, Building 1, Jiayu International Plaza, Songhu Road, Yangpu District,
Shanghai, China
Quality Assured
Offer a forward-looking vision to all of our customers.
Customer Service
We welcome any feedbacks and suggestions to make our customers 100% satisfied.
Qualification Certificates
Having more than 20 qualification certificates, including Innovation Company Certificate and Foreign-related investigation Permission etc.
Customers Testimonials
Thank you for recognizing our high quality products and professional, rigorous and sincere service.
